Hing C. Wong, Ph.D.

Director and Chief Executive Officer

Dr. Wong has served as the President and Chief Executive Officer of Altor BioScience since its inception in 2002. With over thirty years of experience in the biotechnology industry, Dr. Wong has been leading corporate operations including financing, acquisitions, technology licensing, and formation of new companies via spin-off and joint venture.

In 1996, Dr. Wong founded Sunol Molecular Corporation and served as the Chairman and Chief Executive Officer until Sunol Molecular’s assets were sold in 2005. Previously, he served on the Board of Directors of Biosynexus Inc., a biotechnology company formed as part of a joint venture between Sunol Molecular and Virion Systems Inc.

Additionally, Dr. Wong was a member of the Board of Trustees of the Rumbaugh-Goodwin Institute of Cancer Research Inc. Prior to founding Sunol Molecular, Dr. Wong served as the Director of the Biology Skills Center at the Dade Division of Baxter International Inc. From 1983 to 1992, Dr. Wong held various scientific and managerial positions at Cetus/Chiron Corporation including Director of the Department of Microbial Genetics. He is a Principal Investigator of several NIH grants, an inventor of numerous patents and an author of many scientific publications in peer-reviewed journals.

Dr. Wong received his Ph.D. degree from the University of Massachusetts at Amherst and was a postdoctoral fellow at the University of Washington, Seattle.

Altor Board of Directors